TREM2 deficiency eliminates TREM2+ inflammatory macrophages and ameliorates pathology in Alzheimer’s disease mouse models
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Variants in triggering receptor expressed on myeloid cells 2 (TREM2) confer high risk for Alzheimer’s disease (AD) and other neurodegenerative diseases. However, the cell types and mechanisms underlying TREM2’s involvement in neurodegeneration remain to be established. Here, we report that TREM2 is up-regulated on myeloid cells surrounding amyloid deposits in AD mouse models and human AD tissue. TREM2 was detected on CD45hiLy6C+ myeloid cells, but not on P2RY12+ parenchymal microglia. In AD mice deficient for TREM2, the CD45hiLy6C+ macrophages are virtually eliminated, resulting in reduced inflammation and ameliorated amyloid and tau pathologies. These data suggest a functionally important role for TREM2+ macrophages in AD pathogenesis and an unexpected, detrimental role of TREM2 in AD pathology. These findings have direct implications for future development of TREM2-targeted therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Trem2, a myeloid protein involved in microglial survival and proliferation, regulates a checkpoint necessary for DAM and deletion of Trem2 prevents microglial accumulation around Aβ plaques and leads to additional neuritic damage [6, 14–17].”
From Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer’s disease (2018) · cites this paper as [14]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source doesn’t support the claim as written.
In the citing paper
“TREM2 was recently demonstrated to be essential for promoting microglial cell association with plaques44–49.”
From Interplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlight (2018) · cites this paper as [45]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source doesn’t support the claim as written.
In the citing paper
“Although numerous studies have reported that TREM2 expression is upregulated in amyloid plaque-associated microglia in vivo (Frank et al., 2008; Jay et al., 2015), our research is the first to show that PU.1 knockdown abrogates this phenomenon in vitro.”
From PU.1 dictates β-amyloid-induced TREM2 expression upregulation in microglia in a transgenic model of Alzheimer’s disease (2025) · cites this paper as Jay et al., 2015
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source doesn’t support the claim as written.
In the citing paper
“Indeed, manipulation of expression of Trem2, Tyrobp, Cx3cl1/Cx3cr1, IL1β, and IFN-γ have all been shown to have opposing effects on amyloid and tau pathologies [49–51, 55–65].”
From Deletion of Abi3/Gngt2 influences age-progressive amyloid β and tau pathologies in distinctive ways (2022) · cites this paper as [59]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“loss of TREM2 function in AD mouse models restricts the ability of microglia to surround Aβ plaques15,16, proliferate, and convert to DAM10,15,17, which in turn leads to more profound neuritic dystrophy18,19.”
From Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer’s disease (2020) · cites this paper as [16]
Experimental — accuracy not yet measured
34 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Oakley, H., Cole, S. L., Logan, S., Maus, E., Shao, P., Craft, J., Guillozet-Bongaarts, A., Ohno, M., Disterhoft, J., Van Eldik, L., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1202-06.2006 · Cited by 3,530 · cited 2×
“5XFAD mice (The Jackson Laboratory B6SJL-Tg(APPSwFlLon,PSEN1*M146*l286V)) express mutant human APP(695) with Swedish (K670N/M671L), Florida (I716V), and London (V717I) mutations and human PSEN1 with M146L and L286V mutations under control of the Thy1 promoter (Oakley et al., 2006).”
BackgroundTREM2 Variants in Alzheimer's Disease
Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J. S. K., Younkin, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211851 · Cited by 3,020
Variant of TREM2 Associated with the Risk of Alzheimer's Disease
Jonsson, T., Stefansson, H., Steinberg, S., Jonsdottir, I., Jonsson, P. V., Snaedal, J., Bjornsson, S., Huttenlocher, J., Levey, A. I., Lah, J. J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211103 · Cited by 2,558 · cited 1×
“Notably, variants of the immune cell– specific triggering receptor expressed on myeloid cells 2 (TREM2) confer dramatically elevated risk for developing AD (R. Guerreiro et al., 2013; Jonsson et al., 2013).”
BackgroundIdentification of a unique TGF-β–dependent molecular and functional signature in microglia
Butovsky, O., Jedrychowski, M. P., Moore, C. S., Cialic, R., Lanser, A. J., Gabriely, G., Koeglsperger, T., Dake, B., Wu, P. M., Doykan, C. E., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3599 · Cited by 2,543 · cited 3×
“First, we found that TREM2+ cells in AD mouse models 2013; Butovsky et al., 2014), was expressed by parenchymal, nonplaque-associated cells in APPPS1;Trem2+/+ mice (Fig.”
BackgroundSelf-citationIntegrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer’s Disease
Zhang, B., Gaiteri, C., Bodea, L.-G., Wang, Z., McElwee, J., Podtelezhnikov, A. A., Zhang, C., Xie, T., Tran, L., Dobrin, R., et al. (2013) · Cell · doi:10.1016/j.cell.2013.03.030 · Cited by 1,657 · cited 2×
“TREM2, along with its obligate intracellular adaptor DAP12, was identified as a hub gene in systems biology analyses in AD (Forabosco et al., 2013; Zhang et al., 2013), highlighting the central importance of these myeloid cell signaling elements CORRESPONDENCE Bruce T.”
BackgroundThe microglial sensome revealed by direct RNA sequencing
Hickman, S. E., Kingery, N. D., Ohsumi, T. K., Borowsky, M. L., Wang, L.-C., Means, T. K., & El Khoury, J. (2013) · Nature Neuroscience · doi:10.1038/nn.3554 · Cited by 1,511
Alzheimer’s Disease Risk Genes and Mechanisms of Disease Pathogenesis
Karch, C. M., & Goate, A. M. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.05.006 · Cited by 1,357 · cited 1×
“However, recent genome-wide association studies linked polymorphisms in inflammation-related genes to increased AD risk, supporting the conclusion that inflammation can be a causative factor in disease pathology (Karch and Goate, 2015).”
BackgroundMicroglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease
Prinz, M., & Priller, J. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3722 · Cited by 1,329 · cited 1×
“The potential role of peripherally derived macrophages in AD has been controversial (Prinz and Priller, 2014), but it is well accepted that CD45hiLy6C+CCR2+ monocytes enter the central nervous system (CNS) and modulate pathology in other disease contexts (Mildner et al.”
BackgroundWyss-Coray (2006) · doi:10.1038/nm1484 · Cited by 1,284
Cited by
Items 601–683 of 683
Castranio, E. L. (2018) · D-Scholarship@Pitt (University of Pittsburgh)
Influence of lithium in neuron-glia interaction in hippocampal neurons: preliminary study
Rocha, N. K. R., Forlenza, O. V., Kerr, D. S., Brentani, H., & de Paula, V. D. J. R. (2018) · Revista de Medicina · doi:10.11606/issn.1679-9836.v97i6p533-546
Studie zur Rolle N-trunkierter Amyloid-β-Peptide bei der Alzheimer-Krankheit
Gießen, N. M.-E. (2019) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-7657 · Cited by 1
Subramanian, S., Pallati, P. K., Sharma, P., Agrawal, D. K., & Nandipati, K. C. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02365-1
Koch, B. M. E. (2019) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-7716
“Pro-inflammatory molecules can contribute to neurotoxicity including IL-1β, IL-6, IL-10 and TNF-α which are highly abundant markers of Trem2-dependent DAM (Jay et al., 2017; Martin et al., 2017; Wang et al., 2015b; Wang et al., 2016).”
BackgroundResultInfluentialInvestigation of myelin maintenance and turnover by inducible MBP knock-out in adult mice
Meschkat, M. (2019) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-7679
Desimone, A. M. L. (2021) · TSpace (University of Toronto)
Jadhav, V. (2021) · IUScholarWorks (Indiana University) · doi:10.7912/c2/2086
p38α-MAPK-deficient myeloid cells ameliorate symptoms and pathology of APP-transgenic AD micePreprint
Luo, Q., Schnöder, L., Hao, W., Litzenburger, K., Decker, Y., Tomic, I., Menger, M. D., Fassbender, K. C., & Liu, Y. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.10.18.464870
Beckmann, N., Neuhaus, A., Zurbruegg, S., Joller, S., Feuerbach, D., Doelemeyer, A., Schweizer, T., Rudin, S., Neumann, U., Berth, R., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1431273/v1
Mira, H., Díez del Corral, R., & Morales, A. V. (2020) · Frontiers research topics · doi:10.3389/978-2-88963-988-5
(2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811351-6.00026-7
Infection-Induced Systemic Inflammation and Dementia
Osafo, N., Dei, S. O., Akwei, N. A., & Yeboah, K. O. (2022) · Springer eBooks · doi:10.1007/978-981-16-7606-2_2
Emerging Roles of TREM2 in Neurodegenerative Diseases
Kabir, M. T. (2022) · Springer eBooks · doi:10.1007/978-981-16-7606-2_7
TREM2 limits progression of deficits and spreading of tau pathology in micePreprint
Feiten, A., Au, C. G., Sabale, M., van Hummel, A., van der Hoven, J., Deng, Y., Przybyla, M., Bright, F., Butler, T., Delerue, F., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-741896/v2
García‐Alberca, J. M., de Rojas, I., Sánchez‐Mejías, E., Garrido-Martín, D., Gonzalez-Palma, L., Jiménez, S., Pino‐Ángeles, A., Cruz-Gamero, J. M., Mendoza, S., Alarcón‐Martín, E., et al. (2022) · medRxiv · doi:10.1101/2022.11.19.22282342
Ablation of cell-specific cholesterol synthesis affects cerebral β-amyloidosis
Spieth, L. (2023) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-9780
Hanotte, J. L. (2023) · El Servicio de Difusión de la Creación Intelectual (National University of La Plata) · doi:10.35537/10915/161150
Lysenko, S. A., Lysenko, N. M., Muzychenko, O. B., & Botanevych, Y. O. (2023) · Reports of Vinnytsia National Medical University · doi:10.31393/reports-vnmedical-2023-27(4)-24
Sobrecarga de cobre y enfermedad de Alzheimer, búsqueda de posibles blancos terapéuticos
Zubillaga, M. (2023) · El Servicio de Difusión de la Creación Intelectual (National University of La Plata) · doi:10.35537/10915/165188
Neuroinflammation Induces Myelin Damage by Inhibiting Gapdh of Oligodendrocytes in the HippocampusPreprint
Li, Z., Fu, H., Liu, F., Wu, Y., & Wang, T. (2024) · Research Square · doi:10.21203/rs.3.rs-4466807/v1
A Neuroinflammatory View of Alzheimer’s Disease
Anisman, H., Hayley, S. P., & Kusnecov, A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23565-8.00005-3
(2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23565-8.09996-8
Yang, Y., García-Cruzado, M., Zeng, H., Wang, X., Bachiller, S., Camprubí-Ferrer, L., Bahatyrevich-Kharitonik, B., Fernández‐Calle, R., & Deierborg, T. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.19.624204
Alzheimer’s Disease: Hypotheses and therapies
Chen, N. (2025) · Theoretical and Natural Science · doi:10.54254/2753-8818/2024.19968 · Cited by 1
Chan, D., Spires‐Jones, T. L., Provenzano, F. A., Glennon, E. B. C., & Duff, K. (2025) · Oxford University Press eBooks · doi:10.1093/med/9780190065324.003.0020
Panchal, U. R. (2025) · Chapman University Digital Commons (Chapman University) · doi:10.36837/chapman.000657
Endogenous γ-Secretase Is Linked to Phagocytic Activity in Microglial Cells
Williams, E. M., Houser, M. C., Torres, S., Wieckiewicz, N., Sadek, M., Yokomizo, M., & Maesako, M. (2025) · Sensors · doi:10.3390/s25113298
“The triggering receptor expressed on myeloid cells 2 (TREM2) is a type I membrane protein exclusively expressed in microglia [32] and is tightly associated with microglial phagocytic activity [33–35].”
Chen, Y., Zeng, Z., Wei, Z., Zhan, Y., Wu, L., Zhu, X., & Li, M. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5278481
β-Amyloid Pathways in Alzheimer's Disease: Mechanisms and Therapeutic Targets
Bansal, S., Yadav, M., Bisht, P., Bansal, D., Tushir, S., & Rathore, D. (2025) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/0118715273382447250526062100 · Cited by 1
Fluid and Imaging Markers of Glial Reactivity
Suárez‐Calvet, M. (2025) · Springer eBooks · doi:10.1007/978-3-031-80849-4_6 · Cited by 1
Raghuvanshi, S., Mazumder, A., & Das, S. (2025) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/0118715273378092250623064748 · Cited by 1
Change in Mechanical Property of Rat Brain Suffering from Chronic High Intraocular Pressure
Zeng, Y., Zhang, K., Ma, Z., & Qian, X. (2025) · Bioengineering · doi:10.3390/bioengineering12080787
“The decline in the dynamic fluctuation of A β after 4 weeks in this paper may involve enhanced TREM2-dependent phagocytosis by microglia and A β degradation mediated by the repair of lysosomal acidification [64,65].”
The Neuroimmune Landscape of the Lysosomal Storage Disorder Sanfilippo Syndrome
Badell‐Grau, R. A., & Schlachetzki, J. C. M. (2025) · BioEssays · doi:10.1002/bies.70083 · Cited by 1
Alzheimer’s Disease: Pathophysiological and Therapeutical Insights
Tyagi, K., Sarup, P., & Malik, J. (2025) · Nutritional neurosciences · doi:10.1007/978-981-95-2736-6_1 · Cited by 1
Molecular mechanism decipher of Alzheimer’s disease based on single-cell RNA-seq informationPreprint
Jiang, X., Wei, D.-Q., Ye, J., & Gilson, É. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.22.689872
Trem2 R47H and reduced TREM2 expression both mimic human Alzheimer’s disease signatures in micePreprint
Abel, T., Pandey, R. S., Haber, A., Garceau, D. T., Sasner, M., Kotredes, K. P., Cary, G. A., Oblak, A. L., Howell, G. R., Lamb, B. T., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.17.694758 · Cited by 1
Self-citationJoshi, P., Riffel, F., Kumar, S., Villacampa, N., Theil, S., Parhizkar, S., Haass, C., Colonna, M., Heneka, M. T., Arzberger, T., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16829558
Franzmeier, N., Suárez‐Calvet, M., Frontzkowski, L. K., Moore, A. M., Hohman, T. J., Morenas‐Rodríguez, E., Nuscher, B., Shaw, L. M. J., Trojanowski, J. Q., Dichgans, M., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13071124
Additional file 6 of LILRB2-mediated TREM2 signaling inhibition suppresses microglia functions
Zhao, P., Xu, Y., Jiang, L.-L., Fan, X., Ku, Z., Li, L., Liu, X., Deng, M., Arase, H., Zhu, J.-J., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20098700
Additional file 5 of LILRB2-mediated TREM2 signaling inhibition suppresses microglia functions
Zhao, P., Xu, Y., Jiang, L.-L., Fan, X., Ku, Z., Li, L., Liu, X., Deng, M., Arase, H., Zhu, J.-J., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20098697
Additional file 3 of LILRB2-mediated TREM2 signaling inhibition suppresses microglia functions
Zhao, P., Xu, Y., Jiang, L.-L., Fan, X., Ku, Z., Li, L., Liu, X., Deng, M., Arase, H., Zhu, J.-J., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20098691
Additional file 2 of LILRB2-mediated TREM2 signaling inhibition suppresses microglia functions
Zhao, P., Xu, Y., Jiang, L.-L., Fan, X., Ku, Z., Li, L., Liu, X., Deng, M., Arase, H., Zhu, J.-J., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20098688
Additional file 4 of LILRB2-mediated TREM2 signaling inhibition suppresses microglia functions
Zhao, P., Xu, Y., Jiang, L.-L., Fan, X., Ku, Z., Li, L., Liu, X., Deng, M., Arase, H., Zhu, J.-J., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20098694
Additional file 10 of LILRB2-mediated TREM2 signaling inhibition suppresses microglia functions
Zhao, P., Xu, Y., Jiang, L.-L., Fan, X., Ku, Z., Li, L., Liu, X., Deng, M., Arase, H., Zhu, J.-J., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20098679
Additional file 1 of LILRB2-mediated TREM2 signaling inhibition suppresses microglia functions
Zhao, P., Xu, Y., Jiang, L.-L., Fan, X., Ku, Z., Li, L., Liu, X., Deng, M., Arase, H., Zhu, J.-J., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20098685
Delizannis, A. T., Nonneman, A., Tsering, W., Bondt, A. D., den Wyngaert, I. V., Zhang, B., Meymand, E. S., Olufemi, M. F., Koivula, P. P., Maimaiti, S., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16599810
Additional file 8 of LILRB2-mediated TREM2 signaling inhibition suppresses microglia functions
Zhao, P., Xu, Y., Jiang, L.-L., Fan, X., Ku, Z., Li, L., Liu, X., Deng, M., Arase, H., Zhu, J.-J., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20098706
Beckmann, N., Neuhaus, A., Zurbruegg, S., Volkmer, P., Patiño, C., Joller, S., Feuerbach, D., Doelemeyer, A., Schweizer, T., Rudin, S., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22598837
Additional file 7 of LILRB2-mediated TREM2 signaling inhibition suppresses microglia functions
Zhao, P., Xu, Y., Jiang, L.-L., Fan, X., Ku, Z., Li, L., Liu, X., Deng, M., Arase, H., Zhu, J.-J., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20098703
Joshi, P., Riffel, F., Kumar, S., Villacampa, N., Theil, S., Parhizkar, S., Haass, C., Colonna, M., Heneka, M. T., Arzberger, T., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16829555
Additional file 9 of LILRB2-mediated TREM2 signaling inhibition suppresses microglia functions
Zhao, P., Xu, Y., Jiang, L.-L., Fan, X., Ku, Z., Li, L., Liu, X., Deng, M., Arase, H., Zhu, J.-J., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20098712
Zhang, L., Yao, Q., Hu, J., Qiu, B., Xiao, Y., Zhang, Q., Zeng, Y., Zheng, S., Zhang, Y., Wan, Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26672235
Additional file 11 of LILRB2-mediated TREM2 signaling inhibition suppresses microglia functions
Zhao, P., Xu, Y., Jiang, L.-L., Fan, X., Ku, Z., Li, L., Liu, X., Deng, M., Arase, H., Zhu, J.-J., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20098682
Microbiota and Alzheimer's disease: Toward new clinical approaches
Đokić, J., & Dinić, M. (2025) · Medicinski podmladak · doi:10.5937/mp76-60520 · Cited by 1
Klassen, P. C., Alexudis, C., Klose, V., José, N. G. D. S., Huss, A. M., Bachhuber, F., Soylu, Ö., Fazeli, B., Erhart, D. K., Laible, M., et al. (2025) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.70240 · Cited by 1
“19,20 TMEM119isassociatedwithhome-ostatic microglia, as a downregulation of its expression has been shown in disease-associated microglia (DAM) states.”
Systemic Amyloid-β Metabolism in Alzheimer’s Disease
Dong-yu, F., Wang, J., Gu, B. J., Masters, C. L., & Wang, Y. (2026) · Springer eBooks · doi:10.1007/978-981-95-5222-1_7
Introduction to microglial aging and its involvement in neurodegenerative diseases
Ben-Azu, B., Gargus, M., Verkhratsky, A., & Tremblay, M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-27340-7.00007-3 · Cited by 1
Konstantoulea, K., Ramakers, M., Borrie, S. C., T’Syen, D., Moechars, D., Śliwińska, M. A., Pradhan, B., Albertini, G., Baligács, N., Tsaka, G., et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2516774123 · Cited by 1
The role of serotoninergic neurons in amyotrophic lateral sclerosis
Oussini, H. E. (2016) · theses.fr (ABES) · doi:10.70675/2431e8ddzd4e4z4710z81dcz14100daa6294
Vautheny, A. (2019) · theses.fr (ABES) · doi:10.70675/1812d71aze8d9z48d6z87d1z5a23a4e81953
Hemonnot-Girard, A.-L. (2021) · theses.fr (ABES) · doi:10.70675/9c8a4775zd774z494ez9bbazf7566faefa8f
Mechanisms controlling microglial colonization of the forebrain
Bridlance, C. (2023) · theses.fr (ABES) · doi:10.70675/5879aa36z8649z48f9zb359zf349ce3cb429
Role of T-cell immunity in the pathophysiology of Alzheimer’s disease and other Tauopathies
Matta, K. (2024) · theses.fr (ABES) · doi:10.70675/cea4fe5ez67c3z4445z92f7z39af62ba059b
TREM2-Targeting peptide tracer for neuroinflammation PET imaging
Zhang, X., Liu, W., Guo, N., Gao, X., Pu, S., Yang, Y., Zha, X., Ding, K., Shi, D., Zhao, J., et al. (2026) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-026-07929-9 · Cited by 1
遠山, 育., Walker, D. G., Tang, T. M., Mendsaikhan, A., Tooyama, I., SERRANO, G. E., Sue, L. I., BEARCH, T. G., & Lue, L. (2020) · Institutional Repositories DataBase (IRDB)
A perivascular perspective on the immune impacts in cerebral amyloid angiopathy
Eyre, B., & Bonney, S. K. (2026) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x261454165
Shirotani, K., Hatta, D., Watanabe, K., Saito, T., Saido, T. C., & Iwata, N. (2026) · Experimental Neurology · doi:10.1016/j.expneurol.2026.115894 · Cited by 1
Clinical Indication of the Role of Inflammation in Alzheimer’s Disease
Kumar, A., Sarkar, N., Kundu, M., Singh, V., & Dasgupta, D. (2026) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898815646126010010
Shirotani, K., Hatta, D., Watanabe, K., Saito, T., Saido, T. C., & Iwata, N. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.18.724708
“…such as cytokine production, migration, proliferation, cell survival, phagocytosis, compaction of amyloid plaques and synapse elimination (Filipello et al., 2018; Jay et al., 2017, 2015; Mazaheri et al., 2017; Takahashi et al., 2005; Ulrich et al., 2014; Wang et al., 2016, 2015; Yuan et al., 2016).”
InfluentialLow-dose ionizing radiation and cognitive function: evidence, mechanisms, and controversies
Wang, Y., Su, W., Wang, T., Li, K., & Zuo, C. (2026) · Neuroscience · doi:10.1016/j.neuroscience.2026.08.007
Kuhnau, L., Jimenez, G. A., Hack, W. R., Varada, S., Gladen-Kolarsky, N., Kim, S., Klein, F., Banerji, T., Quinn, J. F., Scanlan, T. S., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.31.741838
“Similarly, A -overexpressing mice with a TREM2 deficiency or knock-out have shown a decrease in Iba1 expression [47-50], while TREM2 overexpression increased Iba1 immunostaining [34].”
Hossain, M. M., Adhikari, J., Fardous, J., Ahmed, S., Ferdous, M. T., & Shibly, A. Z. (2026) · Next research. · doi:10.1016/j.nexres.2026.102314
Targeting Microglial Receptors for Alzheimer’s Disease: Translational Barriers from Bench to Bedside
Tang, X., Hasan, I., & Xu, J. (2026) · Neuropharmacology and Therapy · doi:10.15212/npt-2026-0008
Shi, Y., Lin, J., Wu, Y., Xu, S., Zhang, N., Pan, Y., Ren, A., Fang, Y., Huang, Y., Zhang, X., et al. (2026) · iMeta · doi:10.1002/imt2.70163 · Cited by 1
“However, this interpretation has been challenged by accumulating evidence showing that Trem2 ‐ dependent microglia can also adopt inflammation ‐ associated and lipid ‐ dysregulated states that sustain microglial activation and contribute to tissue pathology in specific disease contexts [48, 49].”
Papait, A., Natale, F., Silini, A. R., Sarrapochiello, I. N., Orecchini, E., Sollazzo, R., Rinaudo, M., Farigu, S., Garofalo, N., Mantini, G., et al. (2026) · Translational Neurodegeneration · doi:10.1186/s40035-026-00581-1
“However, its genetic deficiency in AD models has been associated with reduced IL-1β and IL-6 levels and increased expression of anti-inflammatory mediators such as Ym1 and Fizz1 [55].”
TREM2 Orchestrates Myeloid Cell Programming and Immune Dysregulation in Pulmonary HypertensionPreprint
de Oliveira, A. C., da Silva, F., Zhang, Y., Alves, M. D., Pham, A. T., Harris, C. L., Khanfar, S., Abdelnor, R., Alvarez-Castanon, J. V., Philips, C. M., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.18.752808
Mercado, C., Amaro, A., Martínez-Pinto, J., Vidal, R., Jury, N., & Lasagna‐Reeves, C. A. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-04065-x
Gogu, M.-R., Costăchescu, I., Stanciu, G. D., Tamba, B.-I., Ciorpac, M., & Gorgan, L. (2026) · Pharmaceuticals · doi:10.3390/ph19101603
Wang, H., Wang, X., Ai, Q., & Pei, D. (2026) · Neurochemical Research · doi:10.1007/s11064-026-04926-0
“On the other hand, when excessively activated or functionally dysregulated, they may contribute to excessive synaptic pruning and chronic inflammation [ 145, 146].”
Shi, C. H., Zhu, B., Pina-Crespo, J., Chen, W. N., Vo, G. V., Huang, H., Yip, K. Y., & Huang, T. Y. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.10.15.759523 · Cited by 1
Metadata
- Authors
- Jay, T. R., Miller, C. M., Cheng, P. J., Graham, L. C., Bemiller, S., Broihier, M. L., Xu, G., Margevicius, D., Karlo, J. C., Sousa, G. L., Cotleur, A. C., Butovsky, O., Bekris, L., Staugaitis, S. M., Leverenz, J. B., Pimplikar, S. W., Landreth, G. E., Howell, G. R., Ransohoff, R. M., & Lamb, B. T.
- Affiliations
- Cleveland Clinic (US)
- The Lerner Research Institute 1 and 2
- Jackson Laboratory (US)
- Case Western Reserve University (US)
- Brigham and Women's Hospital (US)
- Corresponding author
- Lamb, Bruce T.
- ORCID
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2015-03-02
- Volume
- 212
- Issue
- 3
- Pages
- 287-295
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC4354365
- OpenAlex
- W2155344647
- Cited by
- 682
- References
- 33
- Citations by year
- 2026: 27 · 2025: 56 · 2024: 46 · 2023: 56 · 2022: 74 · 2021: 62 · 2020: 70 · 2019: 59 · 2018: 65 · 2017: 67 · 2016: 54 · 2015: 45
- FWCI
- 41.06
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- The Mouseion at the JAXlibrary (Jackson Laboratory) (submittedVersion, cc-by-nc-sa)
- Funders
- National Institutes of Health (UL1TR000439)
- National Institute on Aging (R01AG023012, AG023012, F31AG048704)
- National Institute of General Medical Sciences (T32GM007250)
- National Institute of Neurological Disorders and Stroke (NS047804, T32NS067431, NS087298, R01NS088137, T32NS077888)
- National Center for Advancing Translational Sciences
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Keywords
- TREM2, Alzheimer's disease, inflammatory macrophages, microglia, amyloid deposits, tau pathology, neuroinflammation, amyloidosis
- MeSH terms
- Age Factors, Aged, Alzheimer Disease, Animals, Disease Models, Animal, Female, Hippocampus, Humans, Macrophages, Male, Membrane Glycoproteins, Mice, Transgenic, Receptors, Immunologic, Up-Regulation, Amyloid beta-Peptides, tau Proteins, Leukocyte Common Antigens
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.